Geode Capital Management’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-95,656
| Closed | -$38.3K | – | 4817 |
|
|
2023
Q3 | $38.3K | Hold |
95,656
| – | – | ﹤0.01% | 4484 |
|
|
2023
Q2 | $66K | Hold |
95,656
| – | – | ﹤0.01% | 4446 |
|
|
2023
Q1 | $755K | Buy |
95,656
+31,460
| +49% | +$110K | ﹤0.01% | 3473 |
|
|
2022
Q4 | $57K | Sell |
64,196
-159
| -0.2% | -$163 | ﹤0.01% | 4561 |
|
|
2022
Q3 | $70K | Hold |
64,355
| – | – | ﹤0.01% | 4689 |
|
|
2022
Q2 | $79K | Buy |
64,355
+6,014
| +10% | +$8.04K | ﹤0.01% | 4669 |
|
|
2022
Q1 | $137K | Sell |
58,341
-9
| -0% | -$21 | ﹤0.01% | 4538 |
|
|
2021
Q4 | $180K | Sell |
58,350
-25
| -0% | -$83 | ﹤0.01% | 4525 |
|
|
2021
Q3 | $237K | Sell |
58,375
-5
| -0% | -$21 | ﹤0.01% | 4370 |
|
|
2021
Q2 | $282K | Sell |
58,380
-5,068
| -8% | -$22.7K | ﹤0.01% | 4195 |
|
|
2021
Q1 | $329K | Buy |
63,448
+431
| +0.7% | +$3K | ﹤0.01% | 3957 |
|
|
2020
Q4 | $420K | Buy |
63,017
+1,574
| +3% | +$12.9K | ﹤0.01% | 3640 |
|
|
2020
Q3 | $625K | Buy |
61,443
+18,190
| +42% | +$214K | ﹤0.01% | 3368 |
|
|
2020
Q2 | $542K | Buy |
43,253
+29,880
| +223% | +$418K | ﹤0.01% | 3348 |
|
|
2020
Q1 | $146K | Sell |
13,373
-2,153
| -14% | -$14.4K | ﹤0.01% | 3642 |
|
|
2019
Q4 | $81K | Hold |
15,526
| – | – | ﹤0.01% | 4012 |
|
|
2019
Q3 | $112K | Hold |
15,526
| – | – | ﹤0.01% | 3924 |
|
|
2019
Q2 | $139K | Hold |
15,526
| – | – | ﹤0.01% | 3876 |
|
|
2019
Q1 | $152K | Hold |
15,526
| – | – | ﹤0.01% | 3806 |
|
|
2018
Q4 | $186K | Buy |
15,526
+1,802
| +13% | +$26.2K | ﹤0.01% | 3700 |
|
|
2018
Q3 | $222K | Hold |
13,724
| – | – | ﹤0.01% | 3741 |
|
|
2018
Q2 | $498K | Buy |
13,724
+4,087
| +42% | +$141K | ﹤0.01% | 3442 |
|
|
2018
Q1 | $300K | Hold |
9,637
| – | – | ﹤0.01% | 3571 |
|
|
2017
Q4 | $372K | Hold |
9,637
| – | – | ﹤0.01% | 3467 |
|
|
2017
Q3 | $205K | Hold |
9,637
| – | – | ﹤0.01% | 3660 |
|
|
2017
Q2 | $193K | Buy |
9,637
+1,104
| +13% | +$22.8K | ﹤0.01% | 3701 |
|
|
2017
Q1 | $190K | Buy |
+8,533
| New | +$134K | ﹤0.01% | 3675 |
|
Other funds holding BLPH
Geode Capital Management's BLPH Position: Q4 2023 in Review
Geode Capital Management sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 95,656 shares — an estimated $38.3K sold.
Geode Capital Management first reported a position in BLPH in Q1 2017 and held it in 27 quarters. The position peaked at $755K in Q1 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.
- Geode Capital Management reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
- Geode Capital Management sold 95,656 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $38.3K.
- Geode Capital Management first reported a position in Bellerophon Therapeutics, Inc. in Q1 2017 and held it in 27 quarters.
- Geode Capital Management's Bellerophon Therapeutics, Inc. position peaked at $755K in Q1 2023.
- 2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.
Based on Geode Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.